Supply Chain Intelligence

Chemomab Therapeutics Ltd. Supply Chain

CMMB supply chain intelligence for Chemomab Therapeutics Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CMMB ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
2Customers
1Debt Items
18Related Chains

Chemomab Therapeutics Ltd. Suppliers

TickerNameConfidenceEvidence
EDSA Edesa Biotech, Inc. 72% Reciprocal relationship from EDSA graph: ly reported that supplies of raw materials and critical components necessary for manufacturing processes have been more challenging and expensive to obtain, a…
MIRM Mirum Pharmaceuticals, Inc. 72% Reciprocal relationship from MIRM graph: with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorit…

Chemomab Therapeutics Ltd. Customers

TickerNameConfidenceEvidence
EDSA Edesa Biotech, Inc. 72% Reciprocal relationship from EDSA graph: Reciprocal relationship from CMMB graph: Reciprocal relationship from EDSA graph: ly reported that supplies of raw materials and critical components necessary…
MIRM Mirum Pharmaceuticals, Inc. 72% Reciprocal relationship from MIRM graph: future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced dem…

Chemomab Therapeutics Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CMMB-DEBT-8719 Warrants outstanding: 17.35 90% xbrl warrant detail from xbrl 2021-03-15.

Chemomab Therapeutics Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Chemomab Therapeutics Ltd..

Chemomab Therapeutics Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Chemomab Therapeutics Ltd..

Chemomab Therapeutics Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LLY Eli Lilly and Company 100.00 2
MRK Merck & Co., Inc. 100.00 2
SNYNF Sanofi 100.00 2
PRQR ProQR Therapeutics N.V. 100.00 2
VYNE VYNE Therapeutics Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
TVTX Travere Therapeutics, Inc. 100.00 2
MESO Mesoblast Limited 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
SHIRE SHIRE 50.00 2
ORANY ORANGE 50.00 2
MANU Manchester 50.00 2
NVS Novartis AG 50.00 2
CMOS CMOS 50.00 2
EDSA Edesa Biotech, Inc. 36.29 1 ['customer', 'supplier']
MIRM Mirum Pharmaceuticals, Inc. 36.29 1 ['customer', 'supplier']
CM Canadian Imperial Bank of Commerce 14.78 2
View CMMB supply chain intel →

Explore the full interactive supply chain map for Chemomab Therapeutics Ltd..

Open CMMB supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map